This study assesses the diagnostic accuracy of transferrinuria and an albumin-specific dipstick assay for detection of renal target organ damage (microalbuminuria) in hypertensive patients in a general practice setting. A spot urine sample of 130 nondiabetic patients with elevated office blood pressure readings (4140 and/ or 90 mmHg) was investigated by measuring albumin to creatinine ratio (ACR) and transferrin to creatinine ratio (TCR) and by using an albumin-specific dipstick test (Micral s ). ACR was considered as comparative gold standard. TCR was elevated (40.19 mg/mmol) in 26 urine samples (20.0% of the test samples). ACR was raised in 29 samples (22.3% of the test samples). Elevated TCR had a sensitivity of 97% and specificity of 91% for detection of microalbuminuria. Positive predicting value for microalbuminuria was 65%; negative predicting value was 99%. Correlation between ACR and TCR was strong (r ¼ 0.96). Dipstick testing for albumin was positive in 23 urine samples (17.7% of the test samples), 27 (20.8%) tests were false positive and six (4.6%) false negative. When dipstick was positive, the sensitivity of detecting microalbuminuria was 79%, and specificity 73%. In conclusion, detection of urinary transferrin in nondiabetic patients with hypertension is strongly associated with urinary albumin excretion. However, assessment of TCR does not identify additional patients with microalbuminuria compared to measurement of ACR alone. The semiquantitative Micral test offers a simple and valuable method to screen hypertensive patients for microalbuminuria in a primary care setting.
Introduction
Renal target organ damage in patients with arterial hypertension is associated with increased cardiovascular risk. Microalbuminuria, a marker for hypertensive renal damage, predicts cardiovascular events in hypertensives [1] [2] [3] [4] and is associated with an increased adjusted relative risk for major cardiovascular events. 5 Microalbuminuria assessment in hypertensive patients improves cardiovascular risk stratification 6 and is cost-effective. 7 Assessment of cardiovascular risk factors and hypertensive target organ damage are common tasks in general practice. To detect microalbuminuria, useful point-of-care test have been developed, for example, semiquantitative albumin-specific dipstick tests that are readily available and can be performed immediately in private practice without sophisticated laboratory techniques. However, these dipstick tests with a low threshold for detection of urinary albumin predominantly are studied in diabetic patients. [8] [9] [10] [11] Data in hypertensive subjects without diabetes are weak compared to the prevalence of patients suffering from arterial hypertension. 12, 13 For the quantitative assessment of microalbuminuria, measurement of the albumin to creatinine ratio (ACR) in a random, single-voided, spot urine sample is recommended by guidelines. [14] [15] [16] Urinary excretion of transferrin is also considered as a marker of glomerular damage. 17 In patients with type 2 diabetes, transferrin is thought to be a marker for early stages of diabetic nephropathy. 18 Some studies have suggested that determination of urinary transferrin excretion is more sensitive than determination of urinary albumin excretion for early detection of glomerular impairment in diabetics [19] [20] [21] and even may predict albuminuria. 22 In nondiabetic subjects with hypertension, transferrinuria does not seem to be a useful marker to follow up with early signs of glomerular dysfunction. 23 Contrary, some investigators consider urinary transferrin excretion as possibly a useful marker of glomerular dysfunction. 24 However, the diagnostic significance of transferrinuria compared to albuminuria in patients with essential hypertension is poorly investigated.
Therefore, the objectives of this work were (1) to examine whether measurement of urinary transferrin excretion identifies additional patients with hypertensive end organ damage compared to standard work-up with assessment of urinary albumin excretion and (2) to assess the diagnostic accuracy of an albumin-specific dipstick assay for the detection of renal target organ damage in hypertensive patients in a general practice setting.
Materials and methods

Participants
Subjects were recruited prospectively from the Medical Outpatient Department of the University Hospital, Basel, Switzerland. The study was approved by the local Ethical Committee. Written informed consent was obtained from all subjects.
The study population consisted of 130 subjects (74 men and 56 women; mean age 56713 years) that consecutively attended our Outpatient Department of General Internal Medicine. Patients with unknown, treated or untreated hypertension were included in the study if the average of two blood pressure reading on initial screening visit was 4140 and/or 90 mmHg. Exclusion criteria were known diabetes mellitus or fasting glucose 47 mmol/l, actual urinary infection or evidence of overt kidney disease were excluded. Three patients with evidence of acute urinary tract infection (leucocytes and erythrocytes in high power field examination of urine) were excluded, 130 subjects had no evidence of confounding factors that can falsify the measurement of urinary protein excretion.
Blood pressure was measured with a standard mercury sphygmomanometer in a sitting position after 5 min of rest. During the baseline visit clinical history, physical examination, routine laboratory profile and urine specimen collection were obtained. Within 2 days after inclusion, a 24-h ambulatory blood pressure monitoring (ABPM) was carried out. Patients with mean values (over 24 h) 4130/80 mmHg in ABPM were classified as newly diagnosed hypertensives or sustained hypertension, patients with mean values below that limit in ABPM were classified as white coat hypertensives. According to ABPM readings, four subgroups were formed and analysed separately: (a) white coat hypertensives, (b) patients with newly diagnosed hypertension, (c) patients with sustained, but untreated hypertension and (d) patients with sustained and treated hypertension.
Analysis of urine
Microalbuminuria was defined as an ACR 42.26 mg/mmol in a clean, midstream, urine sample. Transferrin to creatinine ratio (TCR) 40.19 mg/ mmol was considered as transferrinuria. The ACR was regarded as gold standard for detection of microalbuminuria. Confounding urinary protein or albumin excretion, for example, as a result of haematuria, urinary tract infection, vaginal fluid contamination of urine samples, were excluded before analysis by standard dipstick testing (Combur10, Roche Diagnostics GmBH, Mannheim, Germany).
Creatinine concentrations in urine specimens were measured by enzymatic methods (Wako, Pure Chemical Industries Ltd., Osaka, Japan) with a chemistry analyser (Hitachi 917, Japan). Since computed GFR clearance provides a marked improvement over serum, creatinine, the abbreviated MDRD Study equation 25 was additionally computed in accordance with the K/DOQI clinical practice guidelines for chronic kidney disease. The value of MDRT clearance was crossvalidated with in-house Inulin clearance data, r ¼ 0.76. 26 Urine protein markers, transferrin and albumin, were analysed on a Beckman Coulter Image nephelometry system. The procedures for the measurements of specific urine proteins by nephelometry and the identification of postrenal contaminated samples have been previously described. 27 Micral test (Roche Diagnostics GmBH, Mannheim, Germany) is an immunoassay test. After immersing the strip in the urine sample for 5 s, a colour reaction takes place and the colour is proportional to the albumin concentration in the urine. The Micral test yields a range of semiquantitative results, which are determined by comparing the strip colour with four colour blocks on the vial label corresponding to concentrations approximating 0, 20, 50, 100 mg of albumin/l. 28 According to the manufacturer's instruction, albumin concentrations readings X20 mg/l were classified as positive for microalbuminuria.
Statistical analysis
Results are expressed as means7standard deviation (s.d.). Qualitative parameters are given as a proportion (percentage). Evaluation of sensitivity, specificity, positive and negative predictive values were performed with GB-STAT for Windows, Version V6.0, Dynamic Microsystem Inc. (Silver Spring, MD, USA). For between group comparisons of definite and white coat hypertensives, t-test was applied.
Results
Of 130 patients included in the study, mean office blood pressure (OBP) on screening visit was 158/ 99 mmHg717/10 mmHg. By 24-h ABPM, 95 (73.1%) patients with definite hypertension and 35 (26.9%) subjects with white coat hypertension were identified (Table 1) .
Among all 130 patient, TCR was elevated (40.19 mg/mmol) in 26 (20.0%) subjects. The mean TCR was 1.41 mg/mmol (range 0.21-6.0 mg/mmol) corresponding to a 6.8-fold multiple of the upper reference range. The quantitative measurement of urinary albumin by ACR revealed a microalbuminuria in 29 (22.3%) of all 130 patients. The mean ACR in patients with ACR 42.26 mg/mmol was 14.5 mmol/l (range 2.35-79.0 mg/mmol), corresponding to 6.6-fold multiple of the upper reference range. In all patients with elevated OBP, sensitivity to identify microalbuminuria by TCR was 97% and specificity was 91% (positive predictive value 65%; negative predictive value 99%). Positive likelihood ratio was 12, negative likelihood ratio was 0.03. We identified nine (6.9%) false positive test and none of the TCR measurements was false negative. Subgroup analysis are shown in Table 2 .
We found a strong association of urinary albumin and transferrin excretion. In all 130 patients regression coefficient between ACR and TCR was r ¼ 0.96 (Figure 1 ). Similar result were obtained in patients with definite hypertension (r ¼ 0.94) and patients with white coat hypertension (r ¼ 0.99). We could not find a correlation between 24-h blood pressure monitoring or OBP and ACR or TCR (ro0.2, data not shown).
Using a spot urine specimen in patients with elevated OBP, 23 of 29 samples with an ACR 42.26 mg/mmol and 73 of 101 having an ACR o2.26 mg/mmol were correctly identified by the Micral test. Thus, sensitivity was 79%, specificity 73%, 27 (20.8%) tests were false positive and six (4.6%) false negative. Positive predictive value (PPV) was 46% and negative predictive value (NPV) 92%. As shown in Table 3 sensitivity and specificity was higher in subgroup analysis except in patients with untreated hypertension.
Patients with known hypertension were treated with diuretics (n ¼ 2) and calcium antagonists 
Discussion
Detection of transferrin in a random spot urine seems to be strongly associated with urinary albumin excretion but does not identify additional patients with probable hypertensive end organ damage compared to standard work-up, as albumin transferrin is thought to be a marker of glomerular dysfunction. 17 Owing to a higher isoelectric point, transferrin is less anionic than albumin. Therefore, transferrin is more readily filtered into Bowman's capsule of the glomerulus and thus, probably excreted earlier and in a higher ratio compared to albumin. 17 Indeed, in diabetics, transferrin seems to be a more sensitive determinate of glomerular impairment than albumin. 19 One study showed that in 176 diabetic patients, nearly 50% had an increased excretion of both albumin and transferrin, whereas 13.1% of patients were positive for transferrin alone and only 4.0% for albumin alone. 19 A recent study provided prospective results showing that increased transferrin excretion rate predicts the development of microalbuminuria in type 2 diabetic patients with hypertension and normoalbuminuria. 22 In our nondiabetic study population, the correlation between transferrin and albumin excretion was very high. This finding probably supports the hypothesis that transferrin is in line to albumin as marker for hypertensive glomerular damage. Contrary to the findings in diabetics, our data in nondiabetic patients with elevated blood pressure suggest that detection of transferrinuria does not identify additional patients with renal end organ damage. Compared to diabetic patients, transferrin detection in urine of hypertensives seems not to be an earlier marker of glomerular damage than albumin. Thus, it may be postulated that the mechanism of glomerular damage in hypertensive patients is at least in parts different from diabetic damage of the glomerulus. The impact of elevated systemic blood pressure on intraglomerular haemodynamics depends on changes in the resistance of the afferent and efferent arterioles and is coordinated by the concomitant contraction or relaxation of the mesangium. These autoregulatory mechanisms are important determinants of the filtration rate. Possibly, haemodynamic changes in the glomerulus are more distinctive in arterial hypertension than in diabetes where hyperglycemia-induced alteration basal membrane of the glomerulus plays an important role. 29 Only few studies have been carried out on the association of transferrinuria and elevated blood pressure in nondiabetic hypertensive patients and report no 23 or a weak (r ¼ 0.51 for systolic and r ¼ 0.36 for diastolic blood pressure) correlation. 30 Our study confirms these findings, we found a weak (ro0.20) correlation between TCR and OBP or mean 24-h blood pressure. Other factors as dysfunction of intraglomerular haemodynamics or changes in permeability of the glomerular membrane may be more important determinants for the development of transferrinuria. 23 Generally, assessing urinary transferrin excretion as a diagnostic tool to detect renal end organ damage has been of limited interest in the literature. Our results support the fact that this lack of interest is justified and that measuring of the ACR in an untimed urine sample provides an accurate estimate of the protein or albumin excretion rate.
Compared with measurement of quantitative TCR use of a semiquantitative albumin-specific dipstick test provides less consistent results due to lower sensitivity and specificity. Data concerning diagnostic accuracy of the urinary albumin titrator stick (Micral test) in nondiabetic patients with arterial hypertension is poor. Prior studies comparing results obtained from the Micral test with nephelometry have been conducted predominately in diabetic patients. 10, 11, 31 Our results show moderately lower sensitivity and specificity than a study in 171 hypertensive patient with a comparable study population. 12 In our study, Micral test had clearly more false positive than false negative tests. The number of false positive and false negative results is acceptable since Micral test is a screening rather than a diagnostic or a followup test. Nevertheless, the probability that an individual is truly normoalbuminuric, given a negative Micral test result, is high (negative predictive value 92%). These results are in line with earlier findings. 8 The Micral test seems to offer a simple, useful, and cost-effective 7 point-of- In conclusion, detection of urinary transferrin in nondiabetic patient with hypertension is strongly associated with urinary albumin excretion. However, assessment of TCR does not identify additional patients with microalbuminuria compared to measurement of ACR alone. The semiquantitative Micral test offers a simple and valuable method to screen hypertensive patients for microalbuminuria in a primary care setting.
